Nxstage Medical Inc secures Downside Deviation
of 2.78, Mean Deviation
of 2.14 and Risk Adjusted Performance
of 0.016. In connection with Fundamental Indicators
, Macroaxis technical analysis interface lets you check existing technical drivers of Nxstage Medical as well as the relationship between them. Strictly speaking you can use this information to find out if the firm will indeed mirror its model of past prices or the prices will eventually revert. We found nineteen technical drivers
for Nxstage which can be compared to its peers in the industry. Please verify Nxstage Medical Information Ratio
and Downside Variance
to decide if Nxstage Medical Inc is priced some-what accurately providing market reflects its recent price of 9.85 per share. Given that Nxstage Medical has Jensen Alpha
of 0.0532, we recommend you check Nxstage last-minute market performance to make sure the company can sustain itself at future point. Use Nxstage Medical Inc technical analysis together with your other stock asset holdings to protect against small markets fluctuations as well as to check it against diversification policy that fits your risk preferences.
Use this graph to draw trend lines for Nxstage Medical Inc. You can use it to identify possible trend reversals for Nxstage as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Nxstage price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.
Nxstage Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Nxstage Medical Inc applied against its price change over selected period. The best fit line has a slop of 0.02 %
which means Nxstage Medical Inc will continue generating value for investors. It has 40 observation points and regression sum of squers of 0.62 which is sum of squared deviations of the predicted Nxstage price change against its avarage change.
Nxstage has a best fit line with a correlation coefficient of 0.31. and coefficient of determination of 0.1. Note, that about 21.0%
of the company outstanding shares are owned by corporate insiders